Updates on the Treatment Approach for MCL
ECOG-ACRIN E1411: A Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab Based Induction Followed by Rituximab ± Lenalidomide Consolidation for MCL
By
ASH 2022 Conference Coverage
FEATURING
Mitchell Smith
By
ASH 2022 Conference Coverage
FEATURING
Mitchell Smith
Login to view comments.
Click here to Login
Updates on the Treatment Approach for MCL